Strategy Series
Our articles specific to the six investment strategies we offer. Whether you invest with us or are looking to invest, these
articles can you give you an insight into why we make the decisions we make.
Volatility underscores diversification benefits
Since inception 15 months ago, Marcellus Multi-Asset PMS (MAP-Balanced) has outperformed its benchmark by 2.44% points and Nifty 500 TSR Index by 4.57% points (annualised, net of fees and expenses). At that time, Indian equities had run up significantly and seemed overvalued when macro growth had slowed, the earnings cycle had already peaked and risk […]
Marcellus India Wealth Survey 2025 Indian Affluents & HNIs – So Near, Yet So Far….
Diversification in a Concentrated Portfolio of Compounders
In an uncertain macroeconomic environment shaped by AI disruption and shifting global geopolitics, the Consistent Compounders Portfolio (CCP) strategy has evolved significantly. While maintaining a concentrated portfolio focused on good-quality businesses, we have diversified our top holdings across uncorrelated sectors such as healthcare, auto components, and export-led manufacturing. This deliberate shift away from our historical […]
Navigating India’s Structural Shifts
Earnings Growth in India: Sliding Nifty vs Rising CCP
CCP’s Earnings Have Compounded at 18% Per Annum
Global Compounders: Why have we underperformed the S&P500 in 2026?
Marcellus’ Global Compounders Portfolio (GCP) strategically invests in ~40 deeply moated global companies aligned with megatrends, with an aim to provide steady earnings growth and shareholder wealth compounding. Our underperformance vs S&P500 in 2026 has played out in two parts – in line until Feb’26 and underperformance post that. Two factors explain the underperformance: 1) […]
Isaac Newton and the Madness of Men
Three Years In: Staying Objective Through Market Extremes
Global Compounders: Greatness and Value Capture
Indian Banks Don’t Need More Regulation, They Need More Leverage
Indian banks are often criticized for maintaining higher net interest margins (NIMs) compared to their global peers. However, despite higher NIMs, Indian banks’ average RoE of 6.9% over the past decade lags the average RoE of G7 countries’ banks of 9.2%. More importantly, Indian banks have one of the lowest excess return (RoE less 10-year […]
The Kings Stand Tall as the Storm Approaches
Slowing Growth + Rising Risks = Quality Lenders finally Outperforming
Prudent Corporate: The tollbooth for Indian SIPs
Little Champs: Rising Again on its Sixth Anniversary
After enjoying a splendid run in the first three years of its inception, Little Champs portfolio’s (LCP) returns and earnings growth deteriorated from September 2022 – March 2024. On LCP’s 6th anniversary we focus on what went wrong during this period, the lessons learnt and the course correction we undertook around 18 months ago. The steady […]
Navigating the portfolio amidst SMID challenges
Little Champs: Spotlighting Godrej Agrovet
Spotlighting Eureka Forbes
Marcellus Portfolio Updates & Insights – October 2026
From Our CIO’s Desk The Rebuilding of Indian Consumption. As the traditional drivers of mass Indian consumption stall, our core strategy—the Consistent Compounders Portfolio (CCP)—has rewired its allocations toward high-quality pricing-power franchises, private healthcare providers, and manufacturing exporters. Rather than chasing entry-level consumer volume growth, our investment process focuses on resilient, well-managed businesses positioned […]
Marcellus Portfolio Updates & Insights – September 2026
Marcellus Portfolio Updates & Insights – August 2026
Marcellus Portfolio Updates & Insights – June 2026
MeritorQ: Profiting from the Dislocation in Indian Megacaps
Although India’s 20 most profitable listed companies (the ‘Megacaps’) account for around 50% of the profits generated by the BSE 500 companies, these Megacaps account for just 34% of the BSE500’s market cap (down from 41% a decade ago and 45% nearly two decades ago). Indian retail investors’ fascination with small caps seems to be […]
Rebalancing and the Value Effect
The Risks of Owning an Individual Stock
Why Fundamentals and Valuations Matter
MeritorQ: Low-Risk Investing with Sound Fundamentals
In this newsletter, we discuss the so called “low-risk” anomaly which posits that high beta (or high risk) stocks underperform low beta or (low risk stocks) over the long term i.e. there is NO extra return to be earned from owning riskier stocks. We show that this low-risk anomaly works in India as well. In this context, […]
MeritorQ: Quality Matters
MeritorQ: Minimizing Risk by Focusing on Errors of Commission
MeritorQ: Rebalancing Bonus
Navigating our Rising Giants through the SMID Meltdown
The BSE500 index companies (especially the bottom 250 market-cap companies in the index) have witnessed significant moderation in their earnings in recent quarters. This together with their elevated valuations (especially for the smaller cap stocks) represents a formidable challenge for most smidcap portfolios in India. In this difficult environment, the Rising Giants portfolio companies’ earnings […]
Rising Giants: Spotlighting Godrej Agrovet
Rising Giants: Spotlighting Eureka Forbes
Stress Test for Rising Giants
For more content on our strategy, visit the archives
GO TO ARCHIVESLET’S GET ACQUAINTED
New to Marcellus?
Watch this video to know more about us
4 MIN WATCH
The Gold List
The best collections from the Marcellus Library
FEATURED PODCAST
FEATURED VIDEOS
Recommended Reads
Some of our best reads you shouldn’t miss on Marcellus
Curated Collection
HANDPICKED ARTICLES FOR OUR ACTIVE INVESTORS
